DURHAM – Fortrea Holdings reinstated Jason Knoblauch as chief financial officer after he, the company and his former employer resolved litigation through a settlement and mutual release.
The board acted Sept. 9 and also designated Knoblauch as the company’s principal financial officer, according to a Form 8-K filed Sept. 10. Fortrea said he will continue to receive the compensation package disclosed when he was appointed in June.
A July filing said the Delaware Court of Chancery issued a temporary restraining order July 25 preventing Knoblauch from working as Fortrea’s chief financial officer pending a further court order. His former employer had sued Knoblauch and Fortrea, alleging violations of restrictive covenants and retention of confidential information.
Those claims were allegations. Fortrea’s latest filing said the parties resolved the matter through a settlement agreement and mutual release but did not disclose the settlement terms.
Fortrea placed Knoblauch on paid leave and named board member David Smith interim chief financial officer and principal financial officer on July 27. With Knoblauch’s reinstatement, Smith stepped down from the interim positions and remains a Fortrea director.
Knoblauch was originally appointed June 26, effective July 6. Fortrea said at the time that he had more than 20 years of experience in finance, capital markets and strategic operations. His prior roles included chief financial officer positions at Clario and Curia and finance leadership roles at Pharmaceutical Product Development.
Fortrea lists its principal executive offices at 8 Moore Drive in Durham. Its shares trade on the Nasdaq Stock Market under the ticker FTRE.
